NEWS

Apr 30, 2019
NCI research team, led by Dr. Mark Schiffman at Division of Cancer Epidemiology and Genetics (DCEG), is conducting a “Cervix Image Sharing Protocol (CISP)” study on artificial intelligence (AI) approach for better and low-cost screening and...
Apr 24, 2019
The European medical innovation journal, MedNous, featured a story in its March issue entitled “NCI and Industry: Moving Innovations from the Lab to Patients” authored by Michael Salgaller and Michele Newton. MedNous is both a print and online...
Apr 5, 2019
NIH observed rare disease day on 28th February 2019 to build commitment in helping people with rare diseases through research at National Center for Advancing Translational Sciences (NCATS) and Clinical Center (CC). NCATS selected eleven honorable...

New & Updated Opportunities

Jun 20, 2019

Molecular imaging is a disease-specific targeting modality that promises much more accurate diagnoses of serious diseases such as cancer and infections. Agents are...

Jun 17, 2019

The Biorepositories and Biospecimen Research Branch (BBRB) at the National Cancer Institute (NCI) has sponsored various initiatives for conducting biospecimen research...

Jun 11, 2019

Sialic acid, a monosaccharide widely distributed in glycoproteins and glycolipids, plays an important role in biological processes such as cellular adhesion, cellular...

SPOTLIGHT

The Cure Sickle Cell Initiative was launched by the National Heart, Lung, and Blood Institute (NHLBI) to build a nationwide commitment in finding new treatments and personalized care for this hereditary red blood cell disorder. Sickle cell disease affects about 100,000 Americans, many of whom are African American, and over 20 million people worldwide. Since founded in 1948, NHLBI has the long tradition of advancing research on understanding of the sickle cell disease and improving its clinical care. NHLBI also offers many sickle cell disease resources, including publications and videos to help patients and health professionals to learn about treatment and pain management strategies.

Cure Sickle Cell Initiative will actively engage and positively motivate the sickle cell disease community of patients, family members, caregivers, academic institutions, advocacy groups, pharmaceutical companies, federal agencies and biotechnology companies to work together on a path to...

Read More...